Table 1. Patients' baseline characteristics and ORA parameters.
Treatment | Placebo | P-value | |
---|---|---|---|
Age | |||
Mean±SD | 60.6±11 | 58.8±11.5 | 0.73a |
Sex | |||
Female | 33 (75.0%) | 34 (77.3%) | 0.803b |
Diabetes mellitus | |||
No | 37 (84.1%) | 40 (90.9%) | 0.334b |
Yes | 7 (15.9%) | 4 (9.1%) | |
Hypertension | |||
No | 33 (75.0%) | 36 (81.8%) | 0.437b |
Yes | 11 (25.0%) | 8 (18.2%) | |
Baseline IOP | |||
Mean±SD | 12.4±2.7 | 13±2.8 | 0.329c |
Median (range) | 12 (8–19) | 12 (10–20) | |
Baseline IOPcc | |||
Mean±SD | 15.2±2.7 | 15.5±3.6 | 0.682c |
Baseline IOPg | |||
Mean±SD | 14.5±2.7 | 15.3±3.7 | 0.276c |
Baseline CRF | |||
Mean±SD | 9.5±1.3 | 10.1±2.2 | 0.075c |
Baseline CH | |||
Mean±SD | 9.6±1.4 | 10.5±1.7 | 0.008c |
Abbreviations: CH, corneal hysteresis; CRF, corneal resistance factor; IOPcc, intraocular pressure corneal compensated; IOPg, intraocular pressure Goldmann correlated.
On the basis of t-test.
On the basis of χ2-test.
On the basis of linear mixed model.